Ahmed Shahira A, El-Moselhy Amany, El-Moammaly Amal, El-Shewy Khalid
Department of Parasitology, Faculty of Medicine, Suez Canal University, Ismailia, 41522, Egypt.
Acta Parasitol. 2019 Jun;64(2):394-405. doi: 10.2478/s11686-019-00060-w. Epub 2019 May 8.
Patients on corticosteroids therapy (POCT) are more likely to flare up concealed Strongyloides infection and develop Strongyloides hyperinfection syndrome and/or dissemination. Such critical complications can lead to high mortality rates. Rapid detection methods are, therefore, necessary to detect Strongyloides infection in POCT with the advantage of being applicable in a developing country.
Two hundred POCT have been enrolled in this study to determine the rate of infection with Strongyloides. Three different groups of POCT (Strongyloides infected, non-infected, infected with other parasites) were used to evaluate the antibodies detection capability of two serological techniques (enzyme-linked immunosorbent assay (ELISA) and gelatin particles indirect agglutination (GPIAT) against the results of the gold standard agar plate culture (APC).
With APC, the infection rate of Strongyloides stercoralis in POCT was 9.5% (19/200). POCT with Strongyloides infection displayed related risk factors (job, rural settlements, and soil contact) for infection combined with the subtropical nature of Ismailia Governorate. With regard to serology, ELISA detection results were poor compared to APC with sensitivity and specificity of 42.1% and 82.6%, respectively, and positive and negative predictive values of 72% and 30%. GPIAT appeared to be closely related to APC with sensitivity and specificity of 89.4% and 81.8%, respectively, and positive and negative predictive values of 80.9% and 96.7%. Statistical moderate correlation was detected between GPIAT and ELISA.
The GPIAT technique is more convenient, easier, cheaper and faster to rule out the infection of Strongyloides in POCT. It might be the test of choice for routine immunodiagnosis of human strongyloidiasis.
接受皮质类固醇治疗的患者更容易使隐匿的类圆线虫感染复发,并发展为类圆线虫超感染综合征和/或播散。此类严重并发症可导致高死亡率。因此,需要快速检测方法来检测接受皮质类固醇治疗患者中的类圆线虫感染,其优势在于适用于发展中国家。
本研究纳入了200名接受皮质类固醇治疗的患者以确定类圆线虫感染率。使用三组不同的接受皮质类固醇治疗的患者(感染类圆线虫、未感染、感染其他寄生虫)来评估两种血清学技术(酶联免疫吸附测定(ELISA)和明胶颗粒间接凝集试验(GPIAT))针对金标准琼脂平板培养(APC)结果的抗体检测能力。
通过APC检测,接受皮质类固醇治疗的患者中粪类圆线虫的感染率为9.5%(19/200)。感染类圆线虫的接受皮质类固醇治疗的患者显示出感染的相关危险因素(工作、农村定居点和接触土壤),同时结合了伊斯梅利亚省的亚热带性质。关于血清学,与APC相比,ELISA检测结果较差,敏感性和特异性分别为42.1%和82.6%,阳性和阴性预测值分别为72%和30%。GPIAT似乎与APC密切相关,敏感性和特异性分别为89.4%和81.8%,阳性和阴性预测值分别为80.9%和96.7%。在GPIAT和ELISA之间检测到统计学中度相关性。
GPIAT技术在排除接受皮质类固醇治疗患者中的类圆线虫感染方面更方便、更容易、更便宜且更快。它可能是人类类圆线虫病常规免疫诊断的首选检测方法。